HomeCompareCINC vs DIVO

CINC vs DIVO: Dividend Comparison 2026

CINC yields 6.88% · DIVO yields 6.62%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CINC wins by $550.00 in total portfolio value
10 years
CINC
CINC
● Live price
6.88%
Share price
$29.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.5K
Annual income
$1,065.72
Full CINC calculator →
DIVO
DIVO
● Live price
6.62%
Share price
$44.00
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.0K
Annual income
$1,008.47
Full DIVO calculator →

Portfolio growth — CINC vs DIVO

📍 CINC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCINCDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CINC + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CINC pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CINC
Annual income on $10K today (after 15% tax)
$585.00/yr
After 10yr DRIP, annual income (after tax)
$905.86/yr
DIVO
Annual income on $10K today (after 15% tax)
$562.67/yr
After 10yr DRIP, annual income (after tax)
$857.20/yr
At 15% tax rate, CINC beats the other by $48.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CINC + DIVO for your $10,000?

CINC: 50%DIVO: 50%
100% DIVO50/50100% CINC
Portfolio after 10yr
$31.3K
Annual income
$1,037.10/yr
Blended yield
3.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CINC right now

CINC
Analyst Ratings
4
Buy
3
Hold
Consensus: Buy
Price Target
$48.50
+66.9% upside vs current
Range: $30.00 — $73.00
Altman Z
75.2
Piotroski
2/9
DIVO
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CINC buys
0
DIVO buys
0
No recent congressional trades found for CINC or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCINCDIVO
Forward yield6.88%6.62%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$31.5K$31.0K
Annual income after 10y$1,065.72$1,008.47
Total dividends collected$8.8K$8.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: CINC vs DIVO ($10,000, DRIP)

YearCINC PortfolioCINC Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$11,388$688.23$11,362$661.96+$26.00CINC
2$12,918$732.50$12,860$702.91+$58.00CINC
3$14,599$776.53$14,504$743.56+$95.00CINC
4$16,441$820.16$16,303$783.73+$138.00CINC
5$18,455$863.22$18,268$823.31+$187.00CINC
6$20,652$905.58$20,408$862.17+$244.00CINC
7$23,045$947.11$22,737$900.20+$308.00CINC
8$25,646$987.70$25,266$937.31+$380.00CINC
9$28,468$1,027.26$28,008$973.42+$460.00CINC
10$31,527$1,065.72$30,977$1,008.47+$550.00CINC

CINC vs DIVO: Complete Analysis 2026

CINCStock

CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of treatments for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases. CinCor Pharma, Inc. has a license agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. The company was incorporated in 2018 and is headquartered in Boston, Massachusetts.

Full CINC Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this CINC vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CINC vs SCHDCINC vs JEPICINC vs OCINC vs KOCINC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.